1. Guest, the 'News in Brief' for the week beginning 7th June 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

Rituximab biomarker study update

Discussion in 'BioMedical ME/CFS News' started by Ron, Mar 28, 2018.

  1. Ron

    Ron Established Member (Voting Rights)

    Messages:
    91
    Likes Received:
    872
    http://www.meresearch.org.uk/our-studies/rituximab-biomarker-study-update/

    "Last year, we reported on a newly funded study aimed at developing a biomarker to help predict patients who will respond to treatment with rituximab. Unfortunately, this study will not now be going ahead."


    "Although we are still waiting for publication of the full trial results, it is likely they will not show any benefit of rituximab in ME/CFS patients. With this in mind, Prof. Patrick and ME Research UK jointly made the decision not to proceed with the immunosignature study since, in these trial patients at least, there would be nothing to show."
     

Share This Page